Burney Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Buy |
39,131
+326
| +0.8% | +$145K | 0.59% | 43 |
|
|
2025
Q1 | $18.8M | Buy |
38,805
+1,038
| +3% | +$503K | 0.68% | 35 |
|
|
2024
Q4 | $15.2M | Sell |
37,767
-8,394
| -18% | -$3.38M | 0.54% | 44 |
|
|
2024
Q3 | $21.5M | Buy |
46,161
+7,332
| +19% | +$3.41M | 0.76% | 27 |
|
|
2024
Q2 | $18.2M | Buy |
38,829
+37,997
| +4,567% | +$17.8M | 0.7% | 30 |
|
|
2024
Q1 | $348K | Sell |
832
-5,666
| -87% | -$2.37M | 0.01% | 502 |
|
|
2023
Q4 | $2.64M | Buy |
6,498
+5,815
| +851% | +$2.37M | 0.11% | 201 |
|
|
2023
Q3 | $238K | Buy |
683
+58
| +9% | +$20.2K | 0.01% | 513 |
|
|
2023
Q2 | $220K | Buy |
+625
| New | +$220K | 0.01% | 535 |
|
|
2023
Q1 | – | Sell |
-5,639
| Closed | -$1.63M | – | 579 |
|
|
2022
Q4 | $1.63M | Buy |
5,639
+295
| +6% | +$85.2K | 0.08% | 227 |
|
|
2022
Q3 | $1.55M | Buy |
5,344
+4,440
| +491% | +$1.29M | 0.09% | 237 |
|
|
2022
Q2 | $255K | Sell |
904
-93
| -9% | -$26.2K | 0.01% | 492 |
|
|
2022
Q1 | $260K | Buy |
+997
| New | +$260K | 0.01% | 516 |
|
|
2021
Q1 | – | Sell |
-1,893
| Closed | -$447K | – | 578 |
|
|
2020
Q4 | $447K | Sell |
1,893
-133
| -7% | -$31.4K | 0.02% | 387 |
|
|
2020
Q3 | $551K | Buy |
+2,026
| New | +$551K | 0.03% | 344 |
|